Wolf Administration: Life Science Company Expansion to Bring New Jobs to Chester County

Statement

Governor Tom Wolf announced that Fujirebio Diagnostics, Inc., a manufacturer of in vitro diagnostics (IVD) in Chester County, will expand its operations in southeastern Pennsylvania, creating 41 new jobs and retaining more than 348.

"Fujirebio Diagnostics is a longstanding Chester County company that has been a part of the community for more than 20 years," said Gov. Wolf. "Their expansion will bring new opportunities and competitive wages to the region and enhance southeast Pennsylvania's life science community."

The company will expand its existing location in Malvern and will reconfigure a significant portion of that space to accommodate additional manufacturing. The expansion will support the creation of 41 new jobs in positions for lab technicians, manufacturing engineers, process design scientists and management. The company has pledged to invest $7.74 million into the project.

"Fujirebio Diagnostics, Inc., is thankful for the strong relationship that we have continued to build over many years with the Commonwealth of Pennsylvania," said Jenny Graham, CFO of Fujirebio Diagnostics. "This investment will help increase capacity and hire talented workers and is critical in ensuring that we continue to innovate, develop and provide the highest quality products as possible."

Fujirebio Diagnostics received a funding proposal from the Department of Community and Economic Development (DCED) for a $185,000 Pennsylvania First grant and $123,000 in Job Creation Tax Credits to be distributed upon creation of the new jobs. The project was coordinated by the Governor's Action Team, an experienced group of economic development professionals who report directly to the governor and work with businesses that are considering locating or expanding in Pennsylvania.

Fujirebio Diagnostics is owned by Fujirebio Holdings, Inc., which is owned by Japan-based Miraca Holdings, Inc., and develops and manufactures IVD test kits primarily used for cancer treatments. The company's IVD product line ranges from highly specialized manual testing kits to fully automated routine clinical laboratory testing solutions. In addition to its own product lines, Fujirebio also produces test kits for third party customers.

For more information about the Governor's Action Team or DCED, visit dced.pa.gov, and be sure to stay up-to-date with all of our agency news on Facebook, Twitter, and LinkedIn.

Source